CYP2D6 polymorphism in a Mexican American population

Ricardo Mendoza, Yu-Jui Yvonne Wan, Russell E. Poland, Michael Smith, Yanping Zheng, Nancy Berman, Keh Ming Lin

Research output: Contribution to journalArticle

65 Scopus citations

Abstract

Background: Pharmacogenetic data are largely unavailable for Mexican Americans, despite being one of the largest populations in America. Methods: The CYP2D6 genotype (n = 349) and dextromethorphan hydroxylation phenotype (n = 285) were studied in 380 Mexican American subjects from Los Angeles County. Results: The allelic frequency was 22.8% for CYP2D6*2, 10.3% for CYP2D6*4, 7.4% for CYP2D6*10, 2.3% for CYP2D6*5, 1% for CYP2D6*XN (duplication), and >1% for CYP2D6*3 and CYP2D6*17. By using the published antimode for Caucasians, we identified nine subjects as poor metabolizers, an incidence of 3.2%. Of the eight poor metabolizers who were also genotyped, five either were homozygous for the CYP2D6*4 allele (4 cases) or had a combination of CYP2D6*4 and CYP2D6*5 alleles. The mean log10 dextromethorphan/dextrorphan ratio was -2.47 for those classified as extensive metabolizers. The number of functional alleles among the extensive metabolizers correlated strongly with the phenotype, suggesting a gene-dose effect. Conclusion: Compared with previous reports on Caucasian populations, studies show that Mexican Americans appear to possess a lower rate of CYP2D6*4. Frequencies for the other alleles appear to be less divergent between the two groups. This genotypic pattern might be responsible for the lower rate for the poor metabolizer status, as well as for the faster enzyme activity in the extensive metabolizer subjects that was also reflected in our data.

Original languageEnglish (US)
Pages (from-to)552-560
Number of pages9
JournalClinical Pharmacology and Therapeutics
Volume70
Issue number6
DOIs
StatePublished - 2001
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'CYP2D6 polymorphism in a Mexican American population'. Together they form a unique fingerprint.

  • Cite this

    Mendoza, R., Wan, Y-J. Y., Poland, R. E., Smith, M., Zheng, Y., Berman, N., & Lin, K. M. (2001). CYP2D6 polymorphism in a Mexican American population. Clinical Pharmacology and Therapeutics, 70(6), 552-560. https://doi.org/10.1067/mcp.2001.120675